Marc Ferrante

6PUBLICATIONS
15CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 19, 2024
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis.

An Outtier, Rosanne Janssens, Liese Barbier

|Nov 09, 2022
Screening Failure in a Large Clinical Trial Centre for Inflammatory Bowel Diseases: Rates, Causes, and Outcomes.

An Outtier, Liese Gijbels, Maja Noman

|Oct 12, 2022
Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease-a Case Series.

Sophie Vieujean, Annick Moens, Deborah Hassid

|Jun 16, 2022
Multi-model averaging improves the performance of model-guided infliximab dosing in patients with inflammatory bowel diseases.

Wannee Kantasiripitak, An Outtier, Sebastian G Wicha

|Apr 29, 2022
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis.

Bram Verstockt, Valery Volk, Charlot Jaeckel

Pageof 1